These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 20529825)

  • 61. I-TAC is a dominant chemokine in controlling skin intragraft inflammation via recruiting CXCR3+ cells into the graft.
    Li B; Xu W; Xu L; Jiang Z; Wen Z; Li K; Xiong S
    Cell Immunol; 2010; 260(2):83-91. PubMed ID: 19875106
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CXCR7 mediated Giα independent activation of ERK and Akt promotes cell survival and chemotaxis in T cells.
    Kumar R; Tripathi V; Ahmad M; Nath N; Mir RA; Chauhan SS; Luthra K
    Cell Immunol; 2012; 272(2):230-41. PubMed ID: 22070874
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gene expression profile analyze the molecular mechanism of CXCR7 regulating papillary thyroid carcinoma growth and metastasis.
    Zhang H; Teng X; Liu Z; Zhang L; Liu Z
    J Exp Clin Cancer Res; 2015 Feb; 34(1):16. PubMed ID: 25887589
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
    Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
    Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of CXCR7 extends survival following irradiation of brain tumours in mice and rats.
    Walters MJ; Ebsworth K; Berahovich RD; Penfold ME; Liu SC; Al Omran R; Kioi M; Chernikova SB; Tseng D; Mulkearns-Hubert EE; Sinyuk M; Ransohoff RM; Lathia JD; Karamchandani J; Kohrt HE; Zhang P; Powers JP; Jaen JC; Schall TJ; Merchant M; Recht L; Brown JM
    Br J Cancer; 2014 Mar; 110(5):1179-88. PubMed ID: 24423923
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Emerging roles of atypical chemokine receptor 3 (ACKR3) in normal development and physiology.
    Quinn KE; Mackie DI; Caron KM
    Cytokine; 2018 Sep; 109():17-23. PubMed ID: 29903572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Alteration of CXCR7 expression mediated by TLR4 promotes tumor cell proliferation and migration in human colorectal carcinoma.
    Xu H; Wu Q; Dang S; Jin M; Xu J; Cheng Y; Pan M; Wu Y; Zhang C; Zhang Y
    PLoS One; 2011; 6(12):e27399. PubMed ID: 22180778
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intracellular coexpression of CXC- and CC- chemokine receptors and their ligands in human melanoma cell lines and dynamic variations after xenotransplantation.
    Pinto S; Martínez-Romero A; O'Connor JE; Gil-Benso R; San-Miguel T; Terrádez L; Monteagudo C; Callaghan RC
    BMC Cancer; 2014 Feb; 14():118. PubMed ID: 24559071
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Identification of CXCL11 as part of chemokine network controlling skeletal muscle development.
    Puchert M; Koch C; Zieger K; Engele J
    Cell Tissue Res; 2021 May; 384(2):499-511. PubMed ID: 33502606
    [TBL] [Abstract][Full Text] [Related]  

  • 70. CXCL11 Signaling in the Tumor Microenvironment.
    Gao Q; Zhang Y
    Adv Exp Med Biol; 2021; 1302():41-50. PubMed ID: 34286440
    [TBL] [Abstract][Full Text] [Related]  

  • 71. CXCR3 surface expression in human airway epithelial cells: cell cycle dependence and effect on cell proliferation.
    Aksoy MO; Yang Y; Ji R; Reddy PJ; Shahabuddin S; Litvin J; Rogers TJ; Kelsen SG
    Am J Physiol Lung Cell Mol Physiol; 2006 May; 290(5):L909-18. PubMed ID: 16339779
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The Role of CXCR3 and Associated Chemokines in the Development of Atherosclerosis and During Myocardial Infarction.
    Szentes V; Gazdag M; Szokodi I; Dézsi CA
    Front Immunol; 2018; 9():1932. PubMed ID: 30210493
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Extended N-Terminal Domain Confers Atypical Chemokine Receptor Properties to CXCR3-B.
    D'Uonnolo G; Reynders N; Meyrath M; Abboud D; Uchański T; Laeremans T; Volkman BF; Janji B; Hanson J; Szpakowska M; Chevigné A
    Front Immunol; 2022; 13():868579. PubMed ID: 35720349
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The Role of CXCL11 and its Receptors in Cancer: Prospective but Challenging Clinical Targets.
    Wang J; Ouyang X; Zhu W; Yi Q; Zhong J
    Cancer Control; 2024; 31():10732748241241162. PubMed ID: 38533911
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CXCR7 Targeting and Its Major Disease Relevance.
    Wang C; Chen W; Shen J
    Front Pharmacol; 2018; 9():641. PubMed ID: 29977203
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7.
    Szpakowska M; Decker AM; Meyrath M; Palmer CB; Blough BE; Namjoshi OA; Chevigné A
    Signal Transduct Target Ther; 2021 Jun; 6(1):209. PubMed ID: 34075018
    [No Abstract]   [Full Text] [Related]  

  • 77. Roles for aberrant CXCR3 signaling in basal cell carcinoma: a case for dual activity.
    Yu Y; Merlino G
    Am J Pathol; 2010 May; 176(5):2088-91. PubMed ID: 20185576
    [TBL] [Abstract][Full Text] [Related]  

  • 78. CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.
    Tokunaga R; Zhang W; Naseem M; Puccini A; Berger MD; Soni S; McSkane M; Baba H; Lenz HJ
    Cancer Treat Rev; 2018 Feb; 63():40-47. PubMed ID: 29207310
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The duality of CXCR3 in glioblastoma: unveiling autocrine and paracrine mechanisms for novel therapeutic approaches.
    Chan TYH; Wong JSY; Kiang KM; Sun CWY; Leung GK
    Cell Death Dis; 2023 Dec; 14(12):835. PubMed ID: 38104126
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Interactions of the chemokines CXCL11 and CXCL12 in human tumor cells.
    Koch C; Fischer NC; Puchert M; Engele J
    BMC Cancer; 2022 Dec; 22(1):1335. PubMed ID: 36539774
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.